feed,title,long_url,short_url
Benzinga,"Editas Medicine Is Beyond Skepticism, Analyst Has Confidence In Sickle Cell Therapy, Upgrades Stock",https://benzinga.com/analyst-ratings/analyst-color/23/09/35005301/editas-medicine-is-beyond-skepticism-analyst-has-confidence-in-sickle-cell-therapy-,https://da.gd/l9WyL
